Skip to main content

Future Market Insights Analyzes Impact of COVID-19 on Generic Injectable Market; Stakeholders to Focus on Long-term Dimensions

Generic Injectable Sales Set to Grow Three-fold Between 2019 and 2029; ‘Biologics over Drugs’ Trend Assists Market Growth, Concludes Future Market Insights
Continued supply-demand imbalance in the drug sector is alarming, and pushing key manufacturers to emphasize expansion of manufacturing and distribution capabilities.
Currently at a nascent stage, the global generic injectable market is projected to witness exponential growth in sales at around 12% CAGR during 2019 – 2029. Over the course of forecast period, generic injectable sales will experience 3X growth, as indicated by a new Future Market Insights (FMI) study. Increasing patient preference for self-administration of drugs is primarily developing a fertile ground for the generic injectable market, says the report.
“The generic pharmaceuticals sector is gaining a boost from frequent FDA approvals. Launch of low-cost injectables through investments in consolidations and mergers has been a major highlight,” states the FMI report.
For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6051
Key Takeaways: Generic Injectable Market
  • Demand for monoclonal antibodies (mAbs) would remain significant; vaccines are gaining traction.
  • Generic injectable market continues to see emergence of high-value opportunities in North America and Europe.
  • Asian markets would capture investors’ attention, owing to solid growth in pharma production capacities and technology penetration.
  • High preference for small molecule drugs will prevail
  • Generic injectables continue to witness significant adoption in pain management.
  • Large molecule injectables are set to outperform their small counterparts by 2022.
Key Market Growth Drivers
  • Expansion of orphan drug and parenteral products spaces remains a strong factor driving generic injectable sales.
  • Increasing preference for cost-efficient biologics such as mAbs and vaccines over drugs is in favor of market growth.
  • Reduced development time and increasing manufacturers’ investments in consolidation are bolstering demand for generic injectables.
Key Restraints
  • Hefty operational costs will remain the key constraint facing generic injectable manufacturers.
  • Tightening competition from low-cost manufacturers continues to challenge large-scale players in generic injectable market.
Competition Analysis: Generic Injectable Market
This FMI study has covered some of the most prominent companies active in the generic injectable market, which include, but are not limited to, Pfizer Inc., Hospira Inc., Hikma, and Mylan. Key market players continue to maintain their strategic focus on expansion of business through mergers. Entering strategic distribution agreements will be a preferred move of market leaders in an effort to capture the untapped growth potential of generic injectable market.
Development of new development pipelines and extension of product portfolios continue to be the key strategies of players that look forward to unlock opportunities in the US generic injectable market. Increasing competition to penetrate developed regional markets is attracting investments towards introduction of patented complex biologics. Association with CMOs and CDMOs will be a profitable developmental strategy in terms of productivity and operational costs, says the report.
Request for Covid19 Impact Analysis: https://www.futuremarketinsights.com/covid19/rep-gb-6051
More About the Report
This Future Market Insights study of 239 pages offers actionable insights on the generic injectable market. The market analysis is based on product (monoclonal antibodies, immunoglobulin, cytokines, insulin, peptide hormones, blood factors, peptide antibiotics, vaccines, small molecule antibiotics, chemotherapy agents, and others), molecule type (small molecule and large molecule), application (oncology, infectious diseases, diabetes, blood disorders, hormonal disorders, musculoskeletal disorders, CNS diseases, pain management, and cardiovascular diseases), route of administration (IV, IM, and SC), and distribution channels (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies) across seven regions (Latin America, North America, Europe, South Asia, East Asia, Oceania, and MEA).

Comments

Post a Comment

Popular posts from this blog

Frozen Foods Market Demand, Supply, Growth Factors, Latest Rising Trend and Forecast to 2032

 The Frozen Foods Market has experienced a significant transformation in recent years and continues to be a prominent and dynamic segment of the global food industry. As we move into 2033, this market remains a crucial part of modern lifestyles, offering a wide variety of convenient and preserved food options for consumers. The growth of the Frozen Foods Market is fueled by changing consumer preferences, technological innovations, and an ever-increasing demand for convenient, time-saving, and nutritious meal solutions. In 2033, the Frozen Foods Market is expected to continue its upward trajectory, as more consumers seek the benefits of frozen products. This market encompasses an extensive range of items, from frozen vegetables and fruits to ready-to-eat meals, appetizers, and desserts. The versatility and extended shelf life of frozen foods have made them an essential staple in many households. Consumers are drawn to the convenience of having quick, easy-to-prepare, ...
Post a Comment
Read more

Global ADAS Calibration Equipment Market Projected to Witness a Measurable Downturn; COVID-19 Outbreak Remains a Threat to Growth in the Near Future

  ADAS Calibration Equipment Market Analysis 2019 - 2029 A recent market study published by FMI on the ADAS calibration equipment market includes global industry analysis for 2014 - 2018 & opportunity assessment for 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the ADAS calibration equipment market, the growth prospects of the market are obtained with maximum precision. ADAS Calibration Equipment Market Taxonomy The global ADAS calibration equipment market is segmented in detail to cover every aspect of the market and present complete market intelligence to the reader. Vehicle Passenger Vehicles Commercial Vehicles End User Automotive OEMs Tier 1 Suppliers Service Stations Region North America Latin America Europe South Asia East Asia Oceania Middle East and Africa For more insights into the Market, request a sample of this report@  ...
Post a Comment
Read more

A New Future Market Insights Study Analyses Growth of High Barrier Packaging Films for Pharmaceuticals Market in Light of the Global Corona Virus Outbreak

A recent market study published by Future Market Insights on the high barrier packaging films for pharmaceuticals market includes global industry analysis of 2014-2018 and opportunity assessment for 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on historic as well as current growth parameters, growth prospects of the market are obtained with maximum precision. High Barrier Packaging Films for Pharmaceuticals Market Taxonomy The global  high barrier packaging films for pharmaceuticals market  is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to readers. Product Cold-formable Films Coextruded Films Thermo-formable Films Material Aluminium Plastics Polypropylene(PP) Ethylene Vinyl Alcohol(EVOH) Polyamide Polyethylene Terephthalate(PET) Polyethylene(PE) PVC/PvdC Others (COC, PFTFE, etc.) Application Bags &...
Post a Comment
Read more